KHIDI

Project

Designated as executing institute of the project

Severance has been designated as an executing institute of a research-driven hospital R&D Projects in cooperation with 2 Universities and 9 companies in September 2014.

Goal-Oriented Study selection and planning : Clinical Credentialing

Selection and planning of research considering commercialization starts from analysis of clinical unmet needs, technical feasibility and market feasibility.

Goal-Oriented Study selection and planning
	Meaning of Clinical Credentialing
Unmet Needs	R&D planning of the healthcare industry should start from unmet needs at the hospital where technology demand is rising
Technical Feasibility Analysis	Conduct pre-review for technology needed and analysis of IP
Market Validity Analysis	Need to analyze market validity and whether the technology has competitiveness

Existing R&D (Seeds type)

Technology Development→ Business Development→ market development proceeding sequentially
Takes a long time to commercialize

Research-Driven Hospital R&BD (Needs-type)

Market-Business-Technology development proceeding at the same time
Reduce the time to commercialization

Promoting Project

Project Code: HOPE(Hospital Industrialization through strategic Platform intEgration)
Hospital Industrialization through strategic technology Platform integration for global medical needs
- Cancer Unit Project code : Bio-Manhattan
  Integrated Platform Assisted/Driven Precision Cancer Medicine Delivery System Development
- Immune/Infection Unit Project code : Bio-SETI
  Development of diagnostics and therapeutics for Global Infectious and immunological disorders

Select and specialize Cancer and Immune/Infection units of the 7 core research areas. These 2 units are trying to bring commercialization outcomes based on the integrated technology platform.

Cancer Unit [Bio-Manhattan]

Precise diagnosis of cancer - Commercialization of treatment system

Develop test kit for diagnosis/prognosis of specific solid cancer based on clinical credentialing and possibility of global commercialization
Establish diagnosis/Bio-marker development platform and contribute to human health and industrialization and create the revenue source

Immune/Infection Unit [Bio-SETI]

Development of technology to diagnose and treat global immune/infection diseases

Develop new medical technology to treat and diagnose intractable immune/infection diseases
Lead the industrialization in immune/infection areas and build infrastructure for independent research driven hospitals

<h2 class="depth2_title">Designated as executing institute of the project</h2> <p>Severance has been designated as an executing institute of a research-driven hospital R&D Projects in cooperation with 2 Universities and 9 companies in September 2014.</p> <h2 class="depth2_title02">Goal-Oriented Study selection and planning : Clinical Credentialing</h2> <p>Selection and planning of research considering commercialization starts from analysis of clinical unmet needs, technical feasibility and market feasibility.</p> <table class="mT15 tstyle_list" summary="Meaning of Clinical Credentialing"> <caption>Goal-Oriented Study selection and planning</caption> <thead> <tr> <th></th> <th scope="col">Meaning of Clinical Credentialing</th> </tr> </thead> <tbody> <tr> <th scope="row">Unmet Needs</th> <td class="txt_left">R&D planning of the healthcare industry should start from unmet needs at the hospital where technology demand is rising</td> </tr> <tr> <th scope="row">Technical<br>Feasibility Analysis</th> <td class="txt_left">Conduct pre-review for technology needed and analysis of IP</td> </tr> <tr> <th scope="row">Market<br>Validity Analysis</th> <td class="txt_left">Need to analyze market validity and whether the technology has competitiveness</td> </tr> </tbody> </table> <h3 class="depth3_title">Existing R&D (Seeds type)</h3> <ul class="dot_lstyle"> <li>Technology Development→ Business Development→ market development proceeding sequentially</li> <li>Takes a long time to commercialize</li> </ul> <h3 class="depth3_title02">Research-Driven Hospital R&BD (Needs-type)</h3> <ul class="dot_lstyle"> <li>Market-Business-Technology development proceeding at the same time</li> <li>Reduce the time to commercialization</li> </ul> <h2 class="depth2_title02">Promoting Project</h2> <div class="agency08_04_1"> <ul> <li>Project Code: HOPE(Hospital Industrialization through strategic Platform intEgration) <p>Hospital Industrialization through strategic technology Platform integration for global medical needs</p></li> <li> <ul> <li>Cancer Unit Project code : Bio-Manhattan <p>Integrated Platform Assisted/Driven Precision Cancer Medicine Delivery System Development</p></li> <li>Immune/Infection Unit Project code : Bio-SETI <p>Development of diagnostics and therapeutics for Global Infectious and immunological disorders</p></li> </ul></li> </ul></div> <p class="mT15">Select and specialize Cancer and Immune/Infection units of the 7 core research areas. These 2 units are trying to bring commercialization outcomes based on the integrated technology platform.</p> <h3 class="depth3_title02">Cancer Unit [Bio-Manhattan]</h3> <p class="black_bold">Precise diagnosis of cancer - Commercialization of treatment system</p> <ul class="dot_lstyle"> <li>Develop test kit for diagnosis/prognosis of specific solid cancer based on clinical credentialing and possibility of global commercialization</li> <li>Establish diagnosis/Bio-marker development platform and contribute to human health and industrialization and create the revenue source</li> </ul> <h3 class="depth3_title02">Immune/Infection Unit [Bio-SETI]</h3> <p class="black_bold">Development of technology to diagnose and treat global immune/infection diseases</p> <ul class="dot_lstyle"> <li>Develop new medical technology to treat and diagnose intractable immune/infection diseases</li> <li>Lead the industrialization in immune/infection areas and build infrastructure for independent research driven hospitals</li> </ul>
Source. Press Ctrl + C to copy it to your clipboard.

KRH Designated Agency